1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Isotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stable Isotopes
1.2.3 Radioisotopes
1.3 Market by Application
1.3.1 Global Nuclear Medicine Isotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Nuclear Medicine Isotopes Market Perspective (2017-2028)
2.2 Nuclear Medicine Isotopes Growth Trends by Region
2.2.1 Nuclear Medicine Isotopes Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nuclear Medicine Isotopes Historic Market Size by Region (2017-2022)
2.2.3 Nuclear Medicine Isotopes Forecasted Market Size by Region (2023-2028)
2.3 Nuclear Medicine Isotopes Market Dynamics
2.3.1 Nuclear Medicine Isotopes Industry Trends
2.3.2 Nuclear Medicine Isotopes Market Drivers
2.3.3 Nuclear Medicine Isotopes Market Challenges
2.3.4 Nuclear Medicine Isotopes Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Isotopes Players by Revenue
3.1.1 Global Top Nuclear Medicine Isotopes Players by Revenue (2017-2022)
3.1.2 Global Nuclear Medicine Isotopes Revenue Market Share by Players (2017-2022)
3.2 Global Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Isotopes Revenue
3.4 Global Nuclear Medicine Isotopes Market Concentration Ratio
3.4.1 Global Nuclear Medicine Isotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Isotopes Revenue in 2021
3.5 Nuclear Medicine Isotopes Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Isotopes Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Isotopes Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Nuclear Medicine Isotopes Breakdown Data by Type
4.1 Global Nuclear Medicine Isotopes Historic Market Size by Type (2017-2022)
4.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Type (2023-2028) 5 Nuclear Medicine Isotopes Breakdown Data by Application
5.1 Global Nuclear Medicine Isotopes Historic Market Size by Application (2017-2022)
5.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Nuclear Medicine Isotopes Market Size (2017-2028)
6.2 North America Nuclear Medicine Isotopes Market Size by Type
6.2.1 North America Nuclear Medicine Isotopes Market Size by Type (2017-2022)
6.2.2 North America Nuclear Medicine Isotopes Market Size by Type (2023-2028)
6.2.3 North America Nuclear Medicine Isotopes Market Share by Type (2017-2028)
6.3 North America Nuclear Medicine Isotopes Market Size by Application
6.3.1 North America Nuclear Medicine Isotopes Market Size by Application (2017-2022)
6.3.2 North America Nuclear Medicine Isotopes Market Size by Application (2023-2028)
6.3.3 North America Nuclear Medicine Isotopes Market Share by Application (2017-2028)
6.4 North America Nuclear Medicine Isotopes Market Size by Country
6.4.1 North America Nuclear Medicine Isotopes Market Size by Country (2017-2022)
6.4.2 North America Nuclear Medicine Isotopes Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Nuclear Medicine Isotopes Market Size (2017-2028)
7.2 Europe Nuclear Medicine Isotopes Market Size by Type
7.2.1 Europe Nuclear Medicine Isotopes Market Size by Type (2017-2022)
7.2.2 Europe Nuclear Medicine Isotopes Market Size by Type (2023-2028)
7.2.3 Europe Nuclear Medicine Isotopes Market Share by Type (2017-2028)
7.3 Europe Nuclear Medicine Isotopes Market Size by Application
7.3.1 Europe Nuclear Medicine Isotopes Market Size by Application (2017-2022)
7.3.2 Europe Nuclear Medicine Isotopes Market Size by Application (2023-2028)
7.3.3 Europe Nuclear Medicine Isotopes Market Share by Application (2017-2028)
7.4 Europe Nuclear Medicine Isotopes Market Size by Country
7.4.1 Europe Nuclear Medicine Isotopes Market Size by Country (2017-2022)
7.4.2 Europe Nuclear Medicine Isotopes Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Isotopes Market Size (2017-2028)
8.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type
8.2.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nuclear Medicine Isotopes Market Share by Type (2017-2028)
8.3 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application
8.3.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nuclear Medicine Isotopes Market Share by Application (2017-2028)
8.4 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region
8.4.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Nuclear Medicine Isotopes Market Size (2017-2028)
9.2 Latin America Nuclear Medicine Isotopes Market Size by Type
9.2.1 Latin America Nuclear Medicine Isotopes Market Size by Type (2017-2022)
9.2.2 Latin America Nuclear Medicine Isotopes Market Size by Type (2023-2028)
9.2.3 Latin America Nuclear Medicine Isotopes Market Share by Type (2017-2028)
9.3 Latin America Nuclear Medicine Isotopes Market Size by Application
9.3.1 Latin America Nuclear Medicine Isotopes Market Size by Application (2017-2022)
9.3.2 Latin America Nuclear Medicine Isotopes Market Size by Application (2023-2028)
9.3.3 Latin America Nuclear Medicine Isotopes Market Share by Application (2017-2028)
9.4 Latin America Nuclear Medicine Isotopes Market Size by Country
9.4.1 Latin America Nuclear Medicine Isotopes Market Size by Country (2017-2022)
9.4.2 Latin America Nuclear Medicine Isotopes Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Isotopes Market Size (2017-2028)
10.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type
10.2.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nuclear Medicine Isotopes Market Share by Type (2017-2028)
10.3 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application
10.3.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nuclear Medicine Isotopes Market Share by Application (2017-2028)
10.4 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country
10.4.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Nuclear Medicine Isotopes Introduction
11.1.4 NRG Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.1.5 NRG Recent Developments
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Introduction
11.2.4 NTP Radioisotopes Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.2.5 NTP Radioisotopes Recent Developments
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Nuclear Medicine Isotopes Introduction
11.3.4 JSC Isotope Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.3.5 JSC Isotope Recent Developments
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Nuclear Medicine Isotopes Introduction
11.4.4 ANSTO Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.4.5 ANSTO Recent Developments
11.5 IRE
11.5.1 IRE Company Details
11.5.2 IRE Business Overview
11.5.3 IRE Nuclear Medicine Isotopes Introduction
11.5.4 IRE Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.5.5 IRE Recent Developments
11.6 Nordion
11.6.1 Nordion Company Details
11.6.2 Nordion Business Overview
11.6.3 Nordion Nuclear Medicine Isotopes Introduction
11.6.4 Nordion Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.6.5 Nordion Recent Developments
11.7 Curium Pharma
11.7.1 Curium Pharma Company Details
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Nuclear Medicine Isotopes Introduction
11.7.4 Curium Pharma Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.7.5 Curium Pharma Recent Developments
11.8 Cambridge Isotope Laboratories
11.8.1 Cambridge Isotope Laboratories Company Details
11.8.2 Cambridge Isotope Laboratories Business Overview
11.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Introduction
11.8.4 Cambridge Isotope Laboratories Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.8.5 Cambridge Isotope Laboratories Recent Developments
11.9 Eckert & Ziegler Strahlen
11.9.1 Eckert & Ziegler Strahlen Company Details
11.9.2 Eckert & Ziegler Strahlen Business Overview
11.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Introduction
11.9.4 Eckert & Ziegler Strahlen Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.9.5 Eckert & Ziegler Strahlen Recent Developments
11.10 Polatom
11.10.1 Polatom Company Details
11.10.2 Polatom Business Overview
11.10.3 Polatom Nuclear Medicine Isotopes Introduction
11.10.4 Polatom Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.10.5 Polatom Recent Developments
11.11 Center of Molecular Research
11.11.1 Center of Molecular Research Company Details
11.11.2 Center of Molecular Research Business Overview
11.11.3 Center of Molecular Research Nuclear Medicine Isotopes Introduction
11.11.4 Center of Molecular Research Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.11.5 Center of Molecular Research Recent Developments
11.12 China National Nuclear Corporation
11.12.1 China National Nuclear Corporation Company Details
11.12.2 China National Nuclear Corporation Business Overview
11.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Introduction
11.12.4 China National Nuclear Corporation Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.12.5 China National Nuclear Corporation Recent Developments
11.13 Urenco
11.13.1 Urenco Company Details
11.13.2 Urenco Business Overview
11.13.3 Urenco Nuclear Medicine Isotopes Introduction
11.13.4 Urenco Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.13.5 Urenco Recent Developments
11.14 LANL
11.14.1 LANL Company Details
11.14.2 LANL Business Overview
11.14.3 LANL Nuclear Medicine Isotopes Introduction
11.14.4 LANL Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.14.5 LANL Recent Developments
11.15 Shanghai Engineering Research Center
11.15.1 Shanghai Engineering Research Center Company Details
11.15.2 Shanghai Engineering Research Center Business Overview
11.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Introduction
11.15.4 Shanghai Engineering Research Center Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.15.5 Shanghai Engineering Research Center Recent Developments
11.16 IDB Holland
11.16.1 IDB Holland Company Details
11.16.2 IDB Holland Business Overview
11.16.3 IDB Holland Nuclear Medicine Isotopes Introduction
11.16.4 IDB Holland Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.16.5 IDB Holland Recent Developments
11.17 NHTC
11.17.1 NHTC Company Details
11.17.2 NHTC Business Overview
11.17.3 NHTC Nuclear Medicine Isotopes Introduction
11.17.4 NHTC Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.17.5 NHTC Recent Developments
11.18 Linde
11.18.1 Linde Company Details
11.18.2 Linde Business Overview
11.18.3 Linde Nuclear Medicine Isotopes Introduction
11.18.4 Linde Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.18.5 Linde Recent Developments
11.19 ORNL
11.19.1 ORNL Company Details
11.19.2 ORNL Business Overview
11.19.3 ORNL Nuclear Medicine Isotopes Introduction
11.19.4 ORNL Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.19.5 ORNL Recent Developments
11.20 SI Science
11.20.1 SI Science Company Details
11.20.2 SI Science Business Overview
11.20.3 SI Science Nuclear Medicine Isotopes Introduction
11.20.4 SI Science Revenue in Nuclear Medicine Isotopes Business (2017-2022)
11.20.5 SI Science Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
